journal article·2023-04-12

Biomimetic Nanovesicle with Mitochondria-Synthesized Sonosensitizer and Mitophagy Inhibition for Cancer Sono-Immunotherapy

Liping Zuo, Weidong Nie, Songmao Yu, Wan-Ru Zhuang, Chao Liang, Sucheng Li, Danshu Shi, Guanghao Wu, Xin Sui, Yongheng Li, Hai-Yan Xie

Nano Letters· Volume 23· Issue 7
Publisher page

Abstract

Mitochondria are crucial for both sonodynamic therapy and antitumor immunity. However, how to accurately damage mitochondria and meanwhile prevent the mitophagy and immune checkpoint inhibition is still a great challenge. Herein, hexyl 5-aminolevulinate hydrochloride (HAL) and 3-methyladenine (3MA) are loaded into the tumor cell-derived microparticle (X-MP), which can direct the target delivery of the prepared HAL/3MA@X-MP to the tumor cells. HAL induces the confined biosynthesis and accumulation of sonosensitizer PpIX in mitochondria, leading to the localized generation of reactive oxygen species (ROS) upon ultrasound irradiation and, thus, the efficient mitochondrial damage. Meanwhile, 3MA not only inhibits mitophagy but also down-regulates the PD-L1 expression, promoting the immunogenic cell death (ICD) while blocking the immune checkpoint recognition. The smart synergism of precise mitochondrial damage, mitophagy inhibition and antitumor immunity results in potent therapeutic efficacy without obvious side effects.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Anesthesia and Neurotoxicity Research · Photodynamic Therapy Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, and Chemical Biology Center, Peking University, Beijing 100191, P. R. China

School of Life Science, Beijing Institute of Technology, Beijing 100081, P. R. China

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, P. R. China

Shimadzu (China) Co., LTD, Beijing Branch, Beijing 100020, PR China

School of Materials Science and Engineering, Beijing Institute of Technology, Beijing 100081, P. R. China

Funding

China Postdoctoral Science Foundation · National Natural Science Foundation of China · Beijing Institute of Technology Research Fund Program for Young Scholars

References (33)

Show source-provided references
1. 10.1038/s41467-021-25303-110.1038/s41467-021-25303-1 ↗
2. 10.1002/anie.20190682310.1002/anie.201906823 ↗
3. 10.1021/acscentsci.1c0114310.1021/acscentsci.1c01143 ↗
4. 10.1038/s41467-022-31044-610.1038/s41467-022-31044-6 ↗
5. 10.1002/advs.20200217810.1002/advs.202002178 ↗
6. 10.1039/C9CS00648F10.1039/C9CS00648F ↗
7. 10.1002/adma.20220324610.1002/adma.202203246 ↗
8. 10.1038/s41467-022-31551-610.1038/s41467-022-31551-6 ↗
9. 10.1016/j.biomaterials.2022.12142810.1016/j.biomaterials.2022.121428 ↗
10. 10.1016/j.pmatsci.2020.10068510.1016/j.pmatsci.2020.100685 ↗
11. 10.1002/adma.20180272510.1002/adma.201802725 ↗
12. 10.1021/acscentsci.9b0112110.1021/acscentsci.9b01121 ↗
13. 10.1021/acsami.1c0201910.1021/acsami.1c02019 ↗
14. 10.1002/adma.20190491410.1002/adma.201904914 ↗
15. 10.1002/advs.20200130810.1002/advs.202001308 ↗
16. 10.1038/s41467-021-22594-210.1038/s41467-021-22594-2 ↗
17. 10.1002/advs.20170048110.1002/advs.201700481 ↗
18. 10.1021/acsami.1c2315610.1021/acsami.1c23156 ↗
19. 10.1039/D1NA00427A10.1039/D1NA00427A ↗
20. 10.1016/j.bbrc.2016.10.08810.1016/j.bbrc.2016.10.088 ↗
21. 10.1021/acsami.1c1158310.1021/acsami.1c11583 ↗
22. 10.1080/15548627.2018.146001010.1080/15548627.2018.1460010 ↗
23. 10.1016/j.nantod.2021.10136210.1016/j.nantod.2021.101362 ↗
24. 10.1002/anie.20211779810.1002/anie.202117798 ↗
25. 10.1038/s41467-020-15364-z10.1038/s41467-020-15364-z ↗
26. 10.1126/sciadv.aay978910.1126/sciadv.aay9789 ↗
27. 10.3390/ijms2108296310.3390/ijms21082963 ↗
28. 10.1002/anie.20191370010.1002/anie.201913700 ↗
29. 10.1016/j.biomaterials.2018.11.01910.1016/j.biomaterials.2018.11.019 ↗
30. 10.1016/j.ccell.2016.10.01010.1016/j.ccell.2016.10.010 ↗
31. 10.3389/fimmu.2020.58462610.3389/fimmu.2020.584626 ↗
32. 10.1038/cr.2010.17810.1038/cr.2010.178 ↗
33. 10.1002/jcp.2678310.1002/jcp.26783 ↗